Women's Insights on Extended Adjuvant Endocrine Therapy for Breast Cancer: Qualitative Online Forums Study.

ABSTRACT:

Background

In France, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death among women. For around one-third of women with hormone receptor-positive breast cancer, extending adjuvant endocrine therapy (AET) beyond the initial 5 years is now recommended to reduce the risk of recurrence and mortality. While weighing benefits against potential side effects is essential, little is known about how women seek information about extended AET or how they experience this extension.

Objective

This study aimed to explore, through online forums, women's unmet information needs, the factors influencing their decision-making around extended AET, and the needs and expectations they share throughout the treatment journey.

Methods

A qualitat

SUBMITTER: Cazorla G 

PROVIDER: S-EPMC12688053 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature